Although obesity is generally considered protective against sarcopenia due to its association with greater absolute muscle mass [6], our findings indicate that an increase in irisin levels may be associated with a higher risk of sarcopenic obesity, potentially through simultaneous increases in abdominal adiposity and declines in muscle mass. This evidence concerns the gene FNDC5 and obesity disorder.